Ribbon Shareholders Approve DRC Medicine Merger, But 68% Redeem — Trust Nearly Empty
RIBB sits 26% above its 52-week low of $9.95 on elevated volume (1.9× avg).
Summary
Ribbon shareholders approved the DRC Medicine business combination, but 68% of shares were redeemed for $36.6 million, leaving only $1.41 million in the trust account. The deal now depends heavily on the $100M Meteora equity line.
Key Events · M&A and Partnerships · RIBB
-
Business Combination Approved
All eight proposals received shareholder approval, including the Business Combination Agreement with DRC Medicine Ltd. dated June 30, 2025, and the domestication from Cayman Islands to Delaware.
-
Massive Redemptions Drain Trust
A total of 3,460,471 shares were redeemed for $36,646,387.89 at approximately $10.59 per share. After 30,633 reversal elections, 3,429,838 shares remain subject to redemption for $36,321,984.42, leaving only $1,411,594.05 in the trust account.
-
Post-Merger Cash Crunch
With the trust nearly depleted, the combined company faces minimal cash, a going-concern warning, and a $1.8 million working capital deficit per the Q2 10-Q. The $100M Meteora standby equity purchase agreement becomes the primary funding source.
-
NTA Requirement Removed
Proposal 1 removed the $5,000,001 net tangible assets requirement, allowing the business combination to proceed despite the depleted trust account.
Analysis · RIBB · Real Estate & Construction
At the September 10, 2026 Extraordinary General Meeting, shareholders of Ribbon Acquisition Corp. approved all eight proposals, including the Business Combination with DRC Medicine Ltd. and the domestication to Delaware. However, 3,460,471 shares — roughly 68% of the 5,033,133 outstanding — were redeemed for $36.6 million at $10.59 per share, leaving only $1.41 million in the trust account. This massive redemption wave, combined with the going-concern warning and $1.8 million working capital deficit disclosed in the Q2 10-Q, means the combined company will have minimal cash from the SPAC trust. The $100 million standby equity purchase agreement with Meteora disclosed September 3 becomes critical — it is now the primary funding source for the post-merger entity. The merger can proceed, but the capital structure is severely depleted.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 42.4% of the 495 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RIBB was trading at $12.50 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $63.9M. The 52-week trading range was $9.95 to $18.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.